HealthLIFESTYLE EVUSHELD MONOCLONAL ANTIBODY COMBINATION NOW AVAILABLE IN MALAYSIA’S PRIVATE MARKET FOR PREVENTION OF COVID-19 IN HIGH-RISK INDIVIDUALS by Kevin Chong December 9, 2022 by Kevin Chong December 9, 2022 AstraZeneca’s Evusheld (tixagevimab and cilgavimab, MAL 22056042ACR2), a monoclonal antibody combination, has been launched today… Read more 0 FacebookTwitterWhatsappTelegramLINEEmail